Arsenic Trioxide in Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 Mutation
Clinical trial NCT04489706 · UNKNOWN
Trial details
- NCT number
- NCT04489706
- Sponsor
- Ruijin Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-28
- Primary completion
- 2021-11-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.